Accepted answer
Your friend is right, and the number is large: with a detachable-needle syringe you can lose 40% or more of a vial to dead space, against about 3% with a fixed-needle insulin syringe. Here is the arithmetic, then the presentation comparison.
Dead space, worked properly
Set up a concrete case. A 10 mg vial reconstituted with 2.00 mL of diluent gives 5 mg/mL. A 0.5 mg dose is 0.5 / 5 = 0.10 mL, which is 10 units on a U-100 insulin syringe.
Step 1 — unrecoverable vial residue. You cannot extract the entire fill; some volume stays wetting the walls and below the point the needle can reach at the stopper. For a 2 mL fill in a 3 mL vial, budget about 0.06 mL. Usable volume = 2.00 − 0.06 = 1.94 mL.
Step 2 — per-withdrawal dead space. Dead space is the volume retained in the needle hub and lumen after the plunger bottoms out. It differs by an order of magnitude between designs:
| Syringe type | Dead space per draw | Effective volume consumed per 0.10 mL dose | Doses from 1.94 mL | mg delivered | Loss |
|---|
| 1 mL insulin syringe, permanently attached needle | 0.002–0.005 mL | 0.103 mL | 18.8 → 18 | 9.00 mg | 10.0% |
| 0.3 mL insulin syringe, attached needle, low dead space | 0.001–0.002 mL | 0.1015 mL | 19.1 → 19 | 9.50 mg | 5.0% |
| 1 mL Luer-slip syringe with detachable needle | 0.060–0.080 mL | 0.170 mL | 11.4 → 11 | 5.50 mg | 45.0% |
| 3 mL Luer-lock syringe with detachable needle | 0.080–0.100 mL | 0.190 mL | 10.2 → 10 | 5.00 mg | 50.0% |
Take the third row, which is what you used. Each withdrawal consumes 0.10 mL of dose plus 0.07 mL retained in the hub, so 0.17 mL leaves the vial per dose. 1.94 / 0.17 = 11.4, so 11 doses. Eleven doses of 0.5 mg is 5.5 mg delivered from a 10 mg vial — you lost 4.5 mg, or 45%.
Now the cost consequence. If the vial cost $199, then:
- Nominal: 199 / 10 = $19.90 per mg
- Fixed-needle insulin syringe: 199 / 9.5 = $20.95 per mg
- Your detachable-needle 1 mL syringe: 199 / 5.5 = $36.18 per mg
So the syringe choice was an 82% price increase on the same vial. On a twelve-month course that is the difference between roughly $2,000 and roughly $3,600 of product for identical delivered drug. It is the single largest avoidable cost in the whole vial workflow, it costs nothing to fix, and almost nobody computes it.
Three refinements for completeness. Reconstituting with a larger diluent volume raises the dose volume relative to the fixed dead space and therefore reduces the percentage loss — 4 mL of diluent makes each 0.5 mg dose 0.20 mL, so a 0.07 mL dead space is 26% rather than 41% of the draw. Second, the loss is per withdrawal, so any workflow with more, smaller draws loses proportionally more. Third, a vial stopper tolerates a finite number of punctures before coring becomes a real concern, which independently caps sensible dose count per vial regardless of volume arithmetic.
Why the presentations are not comparable objects
Beyond the milligram count, six differences, in descending order of how much they matter:
- Metered versus measured. A pen delivers its dose by a mechanism calibrated at manufacture. A vial delivers whatever you draw, with your reading error, air bubbles and dead space. Those are different accuracy classes, and the pen's 2.4 mg is a delivered figure while the vial's 10 mg is a content figure.
- Verified versus nominal content. The pen's strength is a release-tested specification with a batch record behind it. The vial's is a label claim whose truth depends on who filled it and whether anyone assayed it.
- Sterility assurance. A sealed licensed presentation used once, against a multi-puncture container you enter repeatedly, with your aseptic technique as the control.
- Formulation. The pen is a defined formulation with buffer, tonicity agent and preservative, developed and stability-tested in its container closure. A powder plus bacteriostatic water is a formulation you assembled, with an unvalidated pH and unknown stability in that specific mixture.
- The 9.6 versus 10 mg framing is itself wrong. A pen carton is four delivered doses; the cartridges contain overfill you never see and are not paying attention to. So the comparison is 9.6 mg guaranteed delivered against, on your numbers, 5.5 mg actually delivered. That is not a 4% difference, it is a 75% one in the other direction.
- Everything non-pharmaceutical. Cold chain, pharmacist counselling, a lot number that maps to a recall system, and an adverse-event reporting route.
Which is the real reason the comparison is apples to oranges: one presentation sells you a delivered, verified dose with a support system, and the other sells you a mass of powder and transfers every remaining step to you. Both have legitimate uses. They do not have a common unit.
edited 4 Mar 2025 by sian_llewellyn — expanded the table to cover the lower concentration
An 82% price increase from the syringe drawer is the most actionable single fact in this entire topic. – lucia_marchetti 4 months ago The overfill point deserves more attention. People compare a delivered dose to a content claim and think they are being rigorous. – tabular_nums 6 months ago 2Larger reconstitution volume reducing percentage loss is the trade-off worth thinking about against concentration accuracy. – tenth_of_a_unit 32 days ago add a comment